Menu

Corvus Pharmaceuticals, Inc. (CRVS) Q3 2026 Earnings Call Transcript
📰

Corvus Pharmaceuticals, Inc. (CRVS) Q3 2026 Earnings Call Transcript

All Articles on Seeking Alpha·6 days ago
#CUBw39m7
#seekingalpha#call#research#corvus#chief
Reading 0:00
15s threshold

Corvus Pharmaceuticals, Inc. ( CRVS ) Q3 2026 Earnings Call November 5, 2026 4:30 PM EST

Company Participants

Leiv Lea - Chief Financial Officer

Richard Miller - Co-Founder, President, CEO & Chairman of the Board

Conference Call Participants

Zack Kubow - Real Chemistry, Inc.

Li Wang Watsek - Cantor Fitzgerald & Co., Research Division

Graig Suvannavejh - Mizuho Securities USA LLC, Research Division

Cha Cha Yang - Jefferies LLC, Research Division

Jeffrey Jones - Oppenheimer & Co. Inc., Research Division

Xun Lee - H.C. Wainwright & Co, LLC, Research Division

Presentation

Operator

Good afternoon, everyone, and thank you for standing by. Welcome to the Corvus Pharmaceuticals Third Quarter 2026 Business Update and Financial Results Conference Call. [Operator Instructions] It is now my pleasure to turn the call over to Zack Kubow, Vice President, Investor Relations and Corporate Communications. Please go ahead, sir.

Zack Kubow

Real Chemistry, Inc.

Thank you, operator, and good afternoon, everyone.…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.